NOVANTA INC
For the period ended Oct 2, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 2, 2026 · Filed Nov 9, 2026
NOVT$145.98+8.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. EXHIBITS
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| ExhibitNumber | Exhibit Description | Form | File No. | Exhibit | FilingDate | Filed/FurnishedHerewith |
| 2.1† | Equity Purchase Agreement, dated as of June 8, 2026, by and among Novanta Medical Technologies Corp., Novanta Corporation, Novanta Inc., Runway Midco, LLC and Runway Buyer, LLC | 8-K | 001-35083 | 2.1 | 06/09/2026 | |
| 3.1 | Certificate and Articles of Continuance of the Registrant, dated March 22, 1999 | S-3 | 333-202597 | 3.1 | 03/09/2015 | |
| 3.2 | By-Laws of the Registrant, as amended | 10-K | 001-35083 | 3.2 | 03/01/2021 | |
| 3.3 | Articles of Reorganization of the Registrant, dated July 23, 2010 | 8-K | 000-25705 | 3.1 | 07/23/2010 | |
| 3.4 | Articles of Amendment of the Registrant, dated May 26, 2005 | 10-K | 001-35083 | 3.4 | 3/1/2023 | |
| 3.5 | Articles of Amendment of the Registrant, dated December 29, 2010 | 8-K | 000-25705 | 3.1 | 12/29/2010 | |
| 3.6 | Articles of Amendment of the Registrant, dated May 11, 2016 | 8-K | 001-35083 | 10.1 | 05/12/2016 | |
| 3.7 | Articles of Amendment of the Registrant, dated April 29, 2022 | 10-Q | 001-35083 | 3.6 | 05/10/2022 | |
| 31.1 | Chief Executive Officer Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | * | ||||
| 31.2 | Chief Financial Officer Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | * | ||||
| 32.1 | Chief Executive Officer Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ** | ||||
| 32.2 | Chief Financial Officer Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ** | ||||
| 101.INS | Inline eXtensible Business Reporting Language (XBRL) Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | * | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | * | ||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | * | ||||
† Certain schedules or appendices to this exhibit have been omitted pursuant to Regulation S-K Item 601(a)(5). A copy of any omitted schedule will be furnished to the Securities and Exchange Commission or its staff upon request.
- Filed herewith
** Furnished herewith
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.